A Roller Coaster Chase for a Cure
By AMY HARMON
The trial of the drug known as PLX4032 has been a series of advances and setbacks at what many see as a watershed moment in understanding genetic changes that cause cancer.
By AMY HARMON
The trial of the drug known as PLX4032 has been a series of advances and setbacks at what many see as a watershed moment in understanding genetic changes that cause cancer.